PMID- 32981813 OWN - NLM STAT- MEDLINE DCOM- 20211124 LR - 20211124 IS - 1873-460X (Electronic) IS - 1056-8727 (Linking) VI - 34 IP - 12 DP - 2020 Dec TI - Increased plasma miR-146a levels are associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus. PG - 107725 LID - S1056-8727(20)30500-6 [pii] LID - 10.1016/j.jdiacomp.2020.107725 [doi] AB - AIMS: The association between circulating miR-146a and subclinical atherosclerosis in type 2 diabetes mellitus (T2DM) remains poorly understood. This study aimed to investigate the correlation between plasma miR-146a levels and subclinical atherosclerosis as measured by the carotid intima-media thickness (CIMT) and brachial-ankle pulse wave velocity (baPWV) in patients with newly diagnosed T2DM. METHODS: We studied 100 patients with newly diagnosed T2DM. Subclinical atherosclerosis was defined as a thickened CIMT (>/=1.0 mm) and high baPWV defined as a value greater than the 75th percentile. Plasma miR-146a levels and metabolic parameters were measured. RESULTS: Patients with thickened CIMT had higher plasma miR-146a levels than those without thickened CIMT (3.36 +/- 1.32 vs 1.38 +/- 1.11, P < 0.001). Patients in the high baPWV group had higher plasma miR-146a levels than those in the normal baPWV group (3.43 +/- 1.32 vs 1.98 +/- 1.48, P < 0.001). Both CIMT (beta = 0.569, P < 0.001) and baPWV (beta = 0.274, P = 0.001) positively correlated with plasma miR-146a levels after adjustment for confounding factors by multiple stepwise regression. On binary logistic regression, plasma miR-146a level was an independent risk factor for thickened CIMT (OR = 3.890, 95% CI 1.415-7.698, P = 0.008) and high baPWV (OR = 1.954, 95% CI 1.256-3.040, P = 0.002) after adjustment for established cardiovascular risk factors. The area under the receiver operating characteristics curve (AUROC) of plasma miR-146a level for predicting thickened CIMT was 0.795 (95%CI 0.708-0.883, P < 0.001) and for predicting high baPWV was 0.773 (95%CI 0.679-0.867, P < 0.001). CONCLUSION: Plasma miR-146a levels correlate with CIMT and baPWV and could act as a biomarker for early diagnosis and as a therapeutic target for atherosclerosis in T2DM. CI - Copyright (c) 2020 Elsevier Inc. All rights reserved. FAU - Guo, Wen AU - Guo W AD - Department of Health Promotion Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. FAU - Li, Xiao-Na AU - Li XN AD - Department of Health Promotion Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. FAU - Li, Jie AU - Li J AD - Department of Endocrinology, Nanjing Central Hospital, Nanjing 210018, China. FAU - Lu, Jing AU - Lu J AD - Department of Health Promotion Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. FAU - Wu, Juan AU - Wu J AD - Department of Health Promotion Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. FAU - Zhu, Wen-Fang AU - Zhu WF AD - Department of Health Promotion Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. FAU - Qin, Pei AU - Qin P AD - Department of Health Promotion Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. Electronic address: pqin1@ualberta.ca. FAU - Xu, Nian-Zhen AU - Xu NZ AD - Department of Health Promotion Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. FAU - Zhang, Qun AU - Zhang Q AD - Department of Health Promotion Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. Electronic address: wenzi20100305@126.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200826 PL - United States TA - J Diabetes Complications JT - Journal of diabetes and its complications JID - 9204583 RN - 0 (MIRN146 microRNA, human) RN - 0 (MicroRNAs) SB - IM MH - Ankle Brachial Index MH - *Atherosclerosis/complications/diagnosis MH - Carotid Intima-Media Thickness MH - *Diabetes Mellitus, Type 2/complications/diagnosis MH - Humans MH - *MicroRNAs/blood MH - Pulse Wave Analysis MH - Risk Factors OTO - NOTNLM OT - CIMT OT - Early atherosclerosis OT - Type 2 diabetes OT - baPWV OT - miR-146a EDAT- 2020/09/29 06:00 MHDA- 2021/11/25 06:00 CRDT- 2020/09/28 05:34 PHST- 2020/05/11 00:00 [received] PHST- 2020/08/02 00:00 [revised] PHST- 2020/08/23 00:00 [accepted] PHST- 2020/09/29 06:00 [pubmed] PHST- 2021/11/25 06:00 [medline] PHST- 2020/09/28 05:34 [entrez] AID - S1056-8727(20)30500-6 [pii] AID - 10.1016/j.jdiacomp.2020.107725 [doi] PST - ppublish SO - J Diabetes Complications. 2020 Dec;34(12):107725. doi: 10.1016/j.jdiacomp.2020.107725. Epub 2020 Aug 26.